Incap Corporation        Stock Exchange Release
22 November 2011 at 9 a.m.


Incap Corporation and Valkee Ltd have signed a cooperation agreement on
manufacturing components of bright light headset, and the first deliveries took
place from Incap's Kuressaare factory in November 2011.

The bright light headset by Valkee Ltd is a new innovation that has attracted
both health care professionals and consumers. Valkee substitutes the mood-
elevating effects of the sun, by channeling safe bright light directly to
photosensitive regions of the brain through the ear canal. That's why Valkee
increases energy, and can act as a preventative or treatment of mood swings and
depression. Valkee has CE Class II(a) medical device certification and is
clinically tested. In a clinical trial by University of Oulu, 9 of 10 people
with seasonal affective disorder felt total symptom relief in four weeks with a
daily 8-12 minute dose. Seasonal affective disorder symptoms include fatigue,
increase of appetite and increased need for sleep, poor quality of sleep and
difficulty to wake up in the mornings during the dark winter months.

Mr Kimmo Akiander, Director of Incap's Business unit Well-being, is satisfied
with the agreement: "People's interest in their own and their family's well-
being is growing all the time. Valkee's brain stimulation headset is a totally
new innovation promoting well-being, and it fits well into Incap's manufacturing
program. We are delighted that Valkee has chosen Incap as a partner in the
manufacture of these devices. "

Cooperation with Valkee is in line with Incap's strategy, as the company aims to
take advantage of global megatrends such as growth in demand for healthcare
technology. Incap's manufacturing program includes a number of medical devices,
and the company has an ISO 13485:2003 quality certification for manufacturing of
medical devices.

Valkee Ltd's CEO Mr Timo Ahopelto comments: "Demand on Valkee's bright light
headset has been growing very strongly and especially internationally. The
Valkee users are satisfied. This partnership will help us meet the demand
according to our high quality standards."

Valkee Ltd is a healthcare technology company which was established in 2007 and
has developed a portable brain stimulation headset to treat seasonal affective
disorder. The company's expertise is based on long-term scientific research and
development in collaboration with the University of Oulu. More information about
the company is available at


For more information:
Sami Mykkänen, President and CEO, tel. +358 40 559 9047
Kimmo Akiander, Business Unit Director, tel. +358 40 839 7966
Hannele Pöllä, Director of Communications and Investor relations, tel.
+358 40 504 8296
NASDAQ OMX Helsinki Ltd.
Principal media
The company's home page

Incap Corporation is an internationally operating contract manufacturer whose
comprehensive services cover the entire life-cycle of electromechanical products
from design and manufacture to maintenance services. Incap's customers include
leading equipment suppliers in energy efficiency and well-being technologies,
for which the company produces competitiveness as a strategic partner. Incap has
operations in Finland, Estonia, India and China. The Group's revenue in 2010
amounted to EUR 59.2 million, and the company currently employs approximately
760 people. Incap's share is listed on the NASDAQ OMX Helsinki. Additional

This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
    other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
     originality of the information contained therein.

Source: Incap Oyj via Thomson Reuters ONE